ClinicalTrials.govpublic full text
Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial for First-line Treatment of Hepatocellular Carcinoma
hepatocellular carcinoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 426784
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.